Dyavanapalli Jhansi, Dergacheva Olga, Wang Xin, Mendelowitz David
Department of Pharmacology and Physiology, The George Washington University, 2300 Eye St NW, Washington, DC, 20037, USA.
Curr Hypertens Rep. 2016 Mar;18(3):22. doi: 10.1007/s11906-016-0630-0.
This brief review focuses on four new topics, with novel and clinically significant consequences, concerning the powerful influence of parasympathetic activity on cardiac function. In this short summary, we will highlight very recent and important work, published in the last 3-4 years, that (1) challenges the paradigm that parasympathetic activity to the heart is involved in the control of heart rate but plays little role in other cardiac functions, (2) characterizes important long-range synaptic pathways to parasympathetic cardiac vagal neurons that are involved in "higher" brain functions (such as arousal and emotional challenges), (3) asks whether implantable chronic vagal nerve stimulation is a promising clinical tool for treating cardiovascular diseases, and (4) describes newly identified neuropeptides and other modulators that can influence the generation and maintenance of parasympathetic activity to the heart.
本简要综述聚焦于四个新主题,这些主题具有新颖且临床意义重大的结果,涉及副交感神经活动对心脏功能的强大影响。在这个简短的总结中,我们将重点介绍过去3 - 4年发表的最新且重要的研究工作,这些工作包括:(1)挑战了关于心脏副交感神经活动参与心率控制但在其他心脏功能中作用甚微的范式;(2)描绘了参与“高级”脑功能(如觉醒和情绪挑战)的副交感神经心脏迷走神经元的重要远程突触通路;(3)探讨植入式慢性迷走神经刺激是否是治疗心血管疾病的一种有前景的临床工具;(4)描述了新发现的可影响心脏副交感神经活动的产生和维持的神经肽及其他调节剂。